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Anhedonia predicts adverse cardiac 
events in people with acute coronary 
syndromes
QUESTION
Question: Does anhedonia and/or depressed mood predict 
recurrent major adverse cardiac events (MACEs) in people 
with acute coronary syndromes (ACS)?
Population: Consecutive sample of 453 people (58% male, mean 
age 61 years, range 25–93 years) hospitalised for ACS: 21% with 
acute myocardial infarction with ST-segment elevation, 33% 
with acute myocardial infarction without ST-segment elevation 
and 46% with unstable angina. To be included, participants had 
to either be not depressed (scoring 0–4 on the Beck Depression 
Inventory, BDI) or have at least mild depression (scoring ≥10 
on the BDI). People scoring 5–9 on the BDI were excluded to 
delineate clearly between depressed and non-depressed people. 
Main exclusions were terminal illness, cognitive impairment and 
alcohol or substance abuse, being unavailable for follow-up or 
screening not completed in the ﬁ rst week.
Setting: Cardiac units in three university hospitals, New York 
and Connecticut, USA; recruitment May 2003 to June 2005.
Prognostic factors: Anhedonia and depressed mood (clinical 
or patient assessed), depressive symptoms severity (BDI score 
<5 vs ≥10), major depressive episodes (MDEs). Participants had 
a semistructured diagnostic interview 1 week after admission 
for ACS. The interview assessed anhedonia, depressed mood 
and Diagnostic and Statistical Manual, Fourth Edition MDEs. 
Symptoms had to be present for at least 2 weeks and clinically 
impairing for clinician-rated anhedonia or depressed mood to 
be diagnosed. Depression symptom severity was assessed with 
the BDI; and patient-reported anhedonia and depressed mood 
were assessed using the BDI items for sadness and crying for 
depressed mood and loss of enjoyment and loss of interest for 
anhedonia. The scores for these items were summed to cre-
ate a score of 0–6 for each of these areas and used to place 
participants in a low or medium group (scores 0–3), and a high 
group (scored 4–6) which indicated severe depressed mood or 
anhedonia. Medical records and patient histories were used 
to provide data for medical covariates including the Global 
Registry of Acute Coronary Events risk score (range 1–263 
points – higher scores having higher mortality risk), Charlson 
comorbidity index, left ventricular ejection fraction and anti-
depressant use. Cox proportional hazard models were used to 
estimate the HR for MACEs and all-cause mortality. Analyses 
were adjusted for age, sex and medical covariates.
Outcomes: MACEs (urgent or emergency coronary revas-
cularisation, hospitalisation for unstable angina, myocardial 
infarction) or all-cause mortality. Participants were contacted 
at 1, 3, 6 and 18 months after the index ACS event by tele-
phone or in person. Hospital records were used to provide 
supporting documentation of outcomes.
METHODS
Design: Cohort study.
Follow-up period: 12 months.
MAIN RESULTS
Clinician-rated anhedonia was diagnosed in 24% (n=108), 
depressed mood in 17% (n=77) and MDE in 11% (n=48) at 
baseline. During follow-up, there were 67 events (14.8%) 
comprising 17 deaths and 50 MACEs. MDE was a signiﬁ cant 
predictor of MACE and all-cause mortality in adjusted analy-
ses, but depressive symptom severity was not (see table 1). 
Both anhedonia and depressed mood predicted age-adjusted 
MACE or all-cause mortality, but when medical covariates, age 
and sex were controlled for, only anhedonia predicted these 
outcomes (anhedonia: HR 1.58, 95% CI 1.16 to 2.14, p<0.01; 
depressed mood: HR 1.28, 95% CI 0.96 to 1.71, p=0.09; see 
table 1). Further adjusting the depressed mood analysis for 
anhedonia and vice versa produced similar ﬁ ndings (see 
table 1). Anhedonia also remained a signiﬁ cant predictor after 
adjustment for MDE or depressive symptom severity (see 
table 1). Results for patient-rated symptoms was similar with 
patient-reported anhedonia signiﬁ cantly predicting MACE or 
all-cause mortality (HR 2.26, 95% CI 1.33 to 3.82, p=0.002) 
but patient-reported depressed mood not a signiﬁ cant predic-
tor (HR 0.86, 95% CI 0.51 to 1.43; p=0.55).
CONCLUSIONS
Anhedonia is a risk factor for recurrent adverse coronary 
events in people with ACS independent of other prognostic 
factors including major depressive episode and depressive 
symptom severity. Depressed mood does not appear to be an 
independent risk factor.
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Davidson and colleagues build on recent research which tries to disentangle the association between symptoms of depression and cardio-
vascular prognosis. For example, de Jonge and col-
leagues1 showed that somatic/affective depressive 
symptoms predicted cardiovascular mortality, but that 
cognitive/affective symptoms did not. Davidson and 
colleagues’ results are more specifi c in that they con-
centrated on two core diagnostic symptoms – anhedo-
nia and depressed mood – with only anhedonia being 
a consistent predictor of prognosis. The results require 
replication, as other recent fi ndings are somewhat con-
tradictory.2 The generalisability of the results may be 
affected by the lower participation rates of Hispanic and 
older patients, while the use of all-cause mortality as an 
end point could be a further biasing factor. Elimination 
of those with intermediate levels of depressive symp-
toms is another acknowledged limitation. Innovatively, 
the authors showed that anhedonia remained predic-
tive when controlling for the effects of major depression 
but also somatic depressive symptoms.
While screening for anhedonia could easily be 
included in clinical practice, it is perhaps unlikely to 
be so, given the relatively ineffective interventions for 
depression available in this population.3 Furthermore, as 
the authors point out, it is unknown if these treatments 
affect anhedonia levels specifi cally. The results highlight 
the probability that the heterogeneity of major depres-
sion criteria has hindered research into this area.2 3 
Re-categorisation of the diagnostic criteria into more 
specifi c subsets may aid future research, for example, 
the use of categories such as ‘anhedonic depression’. 
Overall, information from such studies will likely inform 
more sophisticated, and hopefully successful, interven-
tion trials in cardiac patients in the future.
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